American Heart Journal
Volume 157, Issue 5 , Pages 818-824.e1 , May 2009

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the GRAVITAS trial

  • Matthew J. Price, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic and Scripps Advanced Clinical Trials, La Jolla, CA
    • Corresponding Author InformationReprint requests: Matthew J. Price, MD, 10666 North Torrey Pines Road, Maildrop S1056, La Jolla, CA 92037.
    • ,
  • Peter B. Berger, MD

      Affiliations

    • Geisinger Clinic, Danville, PA
    • ,
  • Dominick J. Angiolillo, MD, PhD

      Affiliations

    • University of Florida College of Medicine-Jacksonville, Jacksonville, FL
    • ,
  • Paul S. Teirstein, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic and Scripps Advanced Clinical Trials, La Jolla, CA
    • ,
  • Jean-François Tanguay, MD

      Affiliations

    • Montreal Heart Institute, Montreal, Quebec, Canada
    • ,
  • David E. Kandzari, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic and Scripps Advanced Clinical Trials, La Jolla, CA
    • ,
  • Christopher P. Cannon, MD

      Affiliations

    • Brigham and Women's Hospital, Boston, MA
    • ,
  • Eric J. Topol, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic and Scripps Advanced Clinical Trials, La Jolla, CA

Received 23 November 2008 ,Accepted 19 February 2009.

 ClinicalTrials.gov identifier: NCT00645918.

PII: S0002-8703(09)00144-6

doi: 10.1016/j.ahj.2009.02.012

American Heart Journal
Volume 157, Issue 5 , Pages 818-824.e1 , May 2009

Article Tools

* Image Usage & Resolution